Logo image of RBLX

ROBLOX CORP -CLASS A (RBLX) Stock Fundamental Analysis

NYSE:RBLX - New York Stock Exchange, Inc. - US7710491033 - Common Stock - Currency: USD

118.82  +0.7 (+0.59%)

After market: 119 +0.18 (+0.15%)

Fundamental Rating

4

RBLX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. The financial health of RBLX is average, but there are quite some concerns on its profitability. RBLX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RBLX has reported negative net income.
In the past year RBLX had a positive cash flow from operations.
RBLX had negative earnings in each of the past 5 years.
RBLX had a positive operating cash flow in each of the past 5 years.
RBLX Yearly Net Income VS EBIT VS OCF VS FCFRBLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

RBLX's Return On Assets of -11.81% is on the low side compared to the rest of the industry. RBLX is outperformed by 69.44% of its industry peers.
Looking at the Return On Equity, with a value of -283.19%, RBLX is doing worse than 80.56% of the companies in the same industry.
Industry RankSector Rank
ROA -11.81%
ROE -283.19%
ROIC N/A
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
RBLX Yearly ROA, ROE, ROICRBLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

The Gross Margin of RBLX (77.92%) is better than 90.28% of its industry peers.
In the last couple of years the Gross Margin of RBLX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for RBLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
RBLX Yearly Profit, Operating, Gross MarginsRBLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

6

2. Health

2.1 Basic Checks

RBLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RBLX has been increased compared to 1 year ago.
The number of shares outstanding for RBLX has been increased compared to 5 years ago.
The debt/assets ratio for RBLX has been reduced compared to a year ago.
RBLX Yearly Shares OutstandingRBLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
RBLX Yearly Total Debt VS Total AssetsRBLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

RBLX has an Altman-Z score of 6.02. This indicates that RBLX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.02, RBLX belongs to the top of the industry, outperforming 84.72% of the companies in the same industry.
The Debt to FCF ratio of RBLX is 1.15, which is an excellent value as it means it would take RBLX, only 1.15 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of RBLX (1.15) is better than 80.56% of its industry peers.
A Debt/Equity ratio of 3.24 is on the high side and indicates that RBLX has dependencies on debt financing.
RBLX's Debt to Equity ratio of 3.24 is on the low side compared to the rest of the industry. RBLX is outperformed by 75.00% of its industry peers.
Even though the debt/equity ratio score it not favorable for RBLX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF 1.15
Altman-Z 6.02
ROIC/WACCN/A
WACC9%
RBLX Yearly LT Debt VS Equity VS FCFRBLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

RBLX has a Current Ratio of 1.02. This is a normal value and indicates that RBLX is financially healthy and should not expect problems in meeting its short term obligations.
RBLX has a Current ratio (1.02) which is in line with its industry peers.
RBLX has a Quick Ratio of 1.02. This is a normal value and indicates that RBLX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of RBLX (1.02) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
RBLX Yearly Current Assets VS Current LiabilitesRBLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

6

3. Growth

3.1 Past

RBLX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.57%, which is quite impressive.
Looking at the last year, RBLX shows a very strong growth in Revenue. The Revenue has grown by 30.24%.
Measured over the past years, RBLX shows a very strong growth in Revenue. The Revenue has been growing by 47.93% on average per year.
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.58%
Revenue 1Y (TTM)30.24%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%30.63%

3.2 Future

RBLX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.20% yearly.
RBLX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.35% yearly.
EPS Next Y0.82%
EPS Next 2Y8.65%
EPS Next 3Y13.2%
EPS Next 5YN/A
Revenue Next Year23.54%
Revenue Next 2Y22.46%
Revenue Next 3Y21.22%
Revenue Next 5Y16.35%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RBLX Yearly Revenue VS EstimatesRBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
RBLX Yearly EPS VS EstimatesRBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RBLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RBLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBLX Price Earnings VS Forward Price EarningsRBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of RBLX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 91.92
EV/EBITDA N/A
RBLX Per share dataRBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as RBLX's earnings are expected to grow with 13.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.65%
EPS Next 3Y13.2%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RBLX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROBLOX CORP -CLASS A

NYSE:RBLX (7/25/2025, 5:36:33 PM)

After market: 119 +0.18 (+0.15%)

118.82

+0.7 (+0.59%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners78.64%
Inst Owner Change-0.13%
Ins Owners4.92%
Ins Owner Change1%
Market Cap80.59B
Analysts76.92
Price Target85.66 (-27.91%)
Short Float %3.96%
Short Ratio2.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.92%
Min EPS beat(2)21.55%
Max EPS beat(2)28.29%
EPS beat(4)4
Avg EPS beat(4)20.7%
Min EPS beat(4)13.59%
Max EPS beat(4)28.29%
EPS beat(8)7
Avg EPS beat(8)15.39%
EPS beat(12)8
Avg EPS beat(12)3.94%
EPS beat(16)9
Avg EPS beat(16)-16.1%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)3.4%
Revenue beat(4)3
Avg Revenue beat(4)3.31%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)8.2%
Revenue beat(8)4
Avg Revenue beat(8)1.35%
Revenue beat(12)4
Avg Revenue beat(12)-5.15%
Revenue beat(16)4
Avg Revenue beat(16)-10.27%
PT rev (1m)13.32%
PT rev (3m)25.59%
EPS NQ rev (1m)4.71%
EPS NQ rev (3m)-7.45%
EPS NY rev (1m)2.53%
EPS NY rev (3m)6.26%
Revenue NQ rev (1m)1.9%
Revenue NQ rev (3m)3.61%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)2.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.01
P/FCF 91.92
P/OCF 78.45
P/B 259.4
P/tB 580.93
EV/EBITDA N/A
EPS(TTM)-1.31
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)1.29
FCFY1.09%
OCF(TTM)1.51
OCFY1.27%
SpS5.66
BVpS0.46
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.81%
ROE -283.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.92%
FCFM 22.86%
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF 1.15
Debt/EBITDA N/A
Cap/Depr 66.47%
Cap/Sales 3.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 6.02
F-Score6
WACC9%
ROIC/WACCN/A
Cap/Depr(3y)189.75%
Cap/Depr(5y)192.24%
Cap/Sales(3y)12.06%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.58%
EPS Next Y0.82%
EPS Next 2Y8.65%
EPS Next 3Y13.2%
EPS Next 5YN/A
Revenue 1Y (TTM)30.24%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%30.63%
Revenue Next Year23.54%
Revenue Next 2Y22.46%
Revenue Next 3Y21.22%
Revenue Next 5Y16.35%
EBIT growth 1Y20.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year195.48%
EBIT Next 3Y54.41%
EBIT Next 5Y39.08%
FCF growth 1Y1181.11%
FCF growth 3Y4.75%
FCF growth 5Y113.37%
OCF growth 1Y165.65%
OCF growth 3Y7.65%
OCF growth 5Y52.65%